New hope for advanced stomach cancer: phase 3 trial launches
NCT ID NCT07118527
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study tests whether a new drug combination (SHR-A1811 plus chemotherapy and adebrelimab) works better than the current standard treatment for people with advanced stomach or gastroesophageal junction cancer that has not been treated before. About 600 adults aged 18 to 75 will be randomly assigned to one of the two treatment groups. The main goals are to see if the new combo delays cancer growth and helps people live longer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC UNTREATED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110001, China
Contact
-
Zhongshan Hospital，Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact
Conditions
Explore the condition pages connected to this study.